Find uplifting stories about heroes, innovations, and solutions
943 results for "mrna vaccines"
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
Scientists have cracked a major puzzle in malaria prevention using mRNA vaccine technology to overcome a natural barrier that weakened previous vaccines. The breakthrough could transform protection against a disease that still causes hundreds of millions of infections each year.
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
Scientists are testing an mRNA vaccine that could be ready before a bird flu pandemic ever starts. Unlike COVID-19, this time we'd have protection waiting on the shelf.
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
Scientists at Harvard have created a new DNA origami vaccine that works as well as mRNA shots but doesn't need freezers and is simpler to manufacture. The breakthrough could make life-saving vaccines accessible to millions more people worldwide.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
Irish researchers have developed a groundbreaking mRNA vaccine that slashed neuroblastoma tumors by 70% in laboratory mice, offering fresh hope for a childhood cancer that kills 15% of young patients. The innovative treatment could be personalized for each child within weeks.
A new type of flu shot using mRNA technology just cleared a major hurdle, bringing us closer to better protection against seasonal flu. The same groundbreaking approach that powered COVID vaccines could soon help millions stay healthier each winter.
Britain just approved its first domestically manufactured mRNA vaccine, marking a major milestone in pandemic preparedness. The new Moderna facility in Oxfordshire can produce up to 250 million doses per year during health emergencies.
Scientists discovered that cancer vaccines harness two immune systems instead of one, potentially doubling their power against tumors. The breakthrough could make experimental cancer treatments work even better for patients.
Scientists at MIT have developed a revolutionary cancer vaccine that completely eliminated tumors in most test mice by supercharging the body's T cells. The breakthrough could transform how we fight cancer and infectious diseases.
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
Abu Dhabi's health authority is partnering with global pharmaceutical leader Sanofi to explore building a cutting-edge vaccine research center powered by AI and mRNA technology. The collaboration could accelerate how quickly new vaccines reach people who need them most.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
Showing 20 of 943